Researchers at the Cleveland Clinic (OH, USA) have discovered bacterial imbalances when comparing healthy and cancerous breast tissue.
In this patient perspective article, you can find out about the challenges associated with diagnosing mesothelioma and the promising role that biomarkers are playing.
This interview with Simon Noble discusses pallitive cancer care development with an emphasis on the management of venous thromboembolism in advanced cancer
In this article from Future Oncology the authors review the current landscape of outlier genes in the field of prostate cancer.
A new study suggests that the ribosomal protein P-S6S240 could represent a marker of poor prognosis and a therapeutic target in uterine leiomyosarcoma.
Prognostic significance of overexpressed p16INK4A in esophageal squamous cell carcinoma: a meta-analysis
This research article from Biomarkers in Medicine explores the prognostic value of p16INK4A in esophageal squamous cell carcinoma patients.
Prognostic factors, predictive markers and cancer biology: the triad for successful oral cancer chemoprevention
In this special report from Future Oncology, the interplay between prognostic factors, predictive markers and cancer biology are discussed in relation to chemoprevention strategies for oral cancer.
Should lysyl oxidase isoforms be considered as a therapeutic target for gastric cancer? Read more in this review from Biomarkers in Medicine.
Could long-noncoding RNAs be utilized as novel circulating biomakers to aid the detection, diagnosis and prognosis of melanoma?
Preclinical investigations suggest that a marker found on the surface of prostate cancer cells – NAALADL2 – could be targeted to potentially halt cancer growth.